Brief: Phibro Animal Health Corporation Welcomes FDA Hearing On Mecadox
12/01/2022 19:02
Jan 12 (Reuters) - Phibro Animal Health Corp PAHC.O :
* PHIBRO ANIMAL HEALTH CORPORATION WELCOMES FDA HEARING ON
MECADOX®
* PHIBRO ANIMAL HEALTH - FDA PROVIDED NOTICE IN FEDERAL
REGISTER
OF ITS INTENTION TO HOLD A PUBLIC HEARING REGARDING MECADOX
* PHIBRO ANIMAL HEALTH CORP - HEARING WILL BE HOSTED BY FDA
AND
WILL TAKE PLACE ON MARCH 10, 2022
Source text for Eikon: ID:nBw3MNh8Va
Further company coverage: PAHC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phibro Animal Health
See all newsPhibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Q4 results beat estimates on mineral nutrition growth
Phibro Animal Health Q3 sales and profit beat estimates
Phibro Animal Health Q2 revenue beats estimates on vaccine demand
Brief: Phibro Animal Health Q2 Adjusted EBITDA USD 68.1 Million